NSEI:PROLIFE

Stock Analysis Report

Executive Summary

Prolife Industries Limited manufactures and sells intermediates for dyes, pigments, pharmaceuticals, agrochemicals, and others in India and internationally.

Snowflake

Fundamentals

Undervalued with excellent balance sheet.

Risks

  • Prolife Industries is not covered by any analysts.

Share Price & News

How has Prolife Industries's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

NSEI:PROLIFE

0.02%

IN Chemicals

-0.7%

IN Market


1 Year Return

-12.9%

NSEI:PROLIFE

-4.2%

IN Chemicals

-12.1%

IN Market

PROLIFE underperformed the Chemicals industry which returned -4.2% over the past year.

PROLIFE matched the India Market (-12.1%) over the past year.


Share holder returns

PROLIFEIndustryMarket
7 Day0%0.02%-0.7%
30 Day4.9%-0.9%-5.7%
90 Day5.3%0.2%-4.3%
1 Year-12.1%-12.9%-3.2%-4.2%-10.4%-12.1%
3 Yearn/a33.8%29.9%19.0%13.0%
5 Yearn/a124.1%111.9%37.9%25.2%

Price Volatility Vs. Market

How volatile is Prolife Industries's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Prolife Industries undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Prolife Industries's share price is below the future cash flow value, and at a moderate discount (> 20%).

Prolife Industries's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Prolife Industries is good value based on earnings compared to the IN Chemicals industry average.

Prolife Industries is good value based on earnings compared to the India market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Prolife Industries, we can't assess if its growth is good value.


Price Based on Value of Assets

Prolife Industries is good value based on assets compared to the IN Chemicals industry average.


Next Steps

Future Growth

How is Prolife Industries expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

6.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Unable to determine if Prolife Industries is high growth as no revenue estimate data is available.

Prolife Industries's earnings are expected to grow by 6.7% yearly, however this is not considered high growth (20% yearly).

Unable to compare Prolife Industries's revenue growth to the India market average as no estimate data is available.

Prolife Industries's earnings growth is positive but not above the India market average.

Prolife Industries's earnings growth is positive but not above the low risk savings rate of 7.6%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Prolife Industries will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Prolife Industries performed over the past 5 years?

39.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Prolife Industries has delivered over 20% year on year earnings growth in the past 5 years.

Prolife Industries's 1-year earnings growth is less than its 5-year average (35.3% vs 39.2%)

Prolife Industries's earnings growth has exceeded the IN Chemicals industry average in the past year (35.3% vs 8.9%).


Return on Equity

Prolife Industries has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Prolife Industries used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.


Return on Capital Employed

Prolife Industries has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Prolife Industries's financial position?


Financial Position Analysis

Prolife Industries is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Prolife Industries's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Prolife Industries's level of debt (59%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (378.2% vs 59% today).

Debt is well covered by operating cash flow (81.6%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 3.7x coverage).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.7x debt.


Next Steps

Dividend

What is Prolife Industries's current dividend yield, its reliability and sustainability?

1.22%

Current Dividend Yield


Dividend Yield and Payments Analysis

Prolife Industries's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.63%).

Prolife Industries's dividend is below the markets top 25% of dividend payers in India (2.52%).

Whilst dividend payments have been stable, Prolife Industries has been paying a dividend for less than 10 years.

Dividend payments have increased, but Prolife Industries only paid a dividend in the past 2 years.


Current Payout to Shareholders

Dividends paid are thoroughly covered by earnings (16.6x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Prolife Industries's salary, the management and board of directors tenure and is there insider trading?

3.0yrs

Average management tenure


CEO

Manindersingh Jolly (54yo)

8.8yrs

Tenure

₹500,000

Compensation

Mr. Manindersingh Satnamsingh Jolly has been the Chairman and Managing Director at Prolife Industries Limited since November 1, 2010. Mr. Jolly is Chairman of Share transfer & Investors Grievance Committee ...


CEO Compensation Analysis

Manindersingh's remuneration is lower than average for companies of similar size in India.

Manindersingh's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

3.0yrs

Average Tenure

The tenure for the Prolife Industries management team is about average.


Board Age and Tenure

8.8yrs

Average Tenure

52yo

Average Age

The tenure for the Prolife Industries board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Manindersingh Jolly (54yo)

    Chairman & MD

    • Tenure: 8.8yrs
    • Compensation: 500.00k
  • Jayvik Soni

    Chief Financial Officer

    • Tenure: 3.0yrs
  • Darshna Maniyar

    Company Secretary & Compliance Officer

    • Tenure: 3.0yrs

Board Members

  • Arun Sehgal

    Non-Executive & Independent Director

  • Manindersingh Jolly (54yo)

    Chairman & MD

    • Tenure: 8.8yrs
    • Compensation: 500.00k
  • Anureet Jolly (52yo)

    Non-Executive & Non-Independent Director

    • Tenure: 9.8yrs
  • Yogesh Pareek (35yo)

    Non-Executive Independent Director

    • Tenure: 1.2yrs

Company Information

Prolife Industries Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Prolife Industries Limited
  • Ticker: PROLIFE
  • Exchange: NSEI
  • Founded: 1994
  • Industry: specialty chemicals
  • Sector: materials
  • Market Cap: ₹100.919m
  • Shares outstanding: 4.09m
  • Website: Click here

Location

  • Prolife Industries Limited
  • Panoli Industrial Estate
  • Plot No. 213
  • Ankleshwar
  • Gujarat
  • 394116
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PROLIFENSEI (National Stock Exchange of India)YesEquity SharesININRJan 2017

Biography

Prolife Industries Limited manufactures and sells intermediates for dyes, pigments, pharmaceuticals, agrochemicals, and others in India and internationally. It also exports its products in the United State ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company AnalysisN/A
End of Day Share Price2019/08/06 00:00
Earnings2019/03/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.